
OUR FULL WEBSITE IS UNDER CONSTRUCTION AND COMING SOON. IN THE MEANTIME DISCOVER VERADERMICS, INC.
Transforming
Medical Dermatology
ABOUT
Founded by dermatologists, Veradermics leverages its front-line clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. The company has cultivated a pipeline of diverse, first-in-class, single-molecule therapeutics for highly prevalent dermatologic conditions seen in adults and children. Target indications include common warts (verruca vulgaris), alopecia areata, molluscum contagiosum, androgenetic alopecia (pattern hair loss), and atopic dermatitis. Veradermics’ lead product candidate, VDMN, offers a new, patient-friendly, injection-free approach for the treatment of common warts. Veradermics is led by an executive team of board-certified dermatologists supported by a board of directors comprised of recognized biopharmaceutical industry leaders.
Veradermics, Inc. is a medical dermatology company advancing first-in-class therapeutics that address real-world patient needs in under-innovated dermatology markets.
Dermatologists Developing First-in-Class Drugs For Dermatology
OUR PIPELINE
We have a rapidly advancing diverse pipeline of first-in-class candidates
Program Indication
MOA Delivery
PRE-IND
PHASE 1
PHASE 2
PHASE 3
VDMN
Common Warts
Candida Antigen Extract
Immunotherapy
Dissolvable Microarray
VDMC
Molluscum Contagiosum
Topical
New Chemical Entity
Antiviral
VDAA
Alopecia Areata
Confidential
Topical against
Clinically Validated Target
VDPHL
Pattern Hair Loss
Confidential
Oral against
Clinically Validated Target
VDAD
Atopic Dermatitis
Oral
New Chemical Entity
Against Clinically Validated Target
Addressing Pervasive Treatment Challenges in Dermatology



Veradermics has cultivated a dermatology-focused pipeline of five novel product candidates for large-market conditions seen in adults and children that are overdue for new treatment approaches including common warts, molluscum contagiosum, alopecia areata, androgenetic alopecia (pattern hair loss), and atopic dermatitis.
Connect With Us
To learn more about Veradermics, please complete the form below and we will be in touch.